Retraction: Recombinant Human Erythropoietin Improves Angiogenesis and Wound Healing in Experimental Burn Wounds (Crit Care Med (2006) 34 (1139-1146) DOI: 10.1097/01.CCM.0000206468.18653.EC);Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds

Critical Care Medicine

Volumn 34, Issue 4, 2006, Pages 1139-1146

  Galeano, Mariarosaria ^a   Altavilla, Domenica ^a   Bitto, Alessandra ^a   Minutoli, Letteria ^a   Calò, Margherita ^a   Lo Cascio, Patrizia ^a   Polito, Francesca ^a   Giugliano, Giovanni ^b   Squadrito, Giovanni ^a   Mioni, Chiara ^c   Giuliani, Daniela ^c   Venuti, Francesco S ^a   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Endothelial nitric oxide synthase; Inducible nitric oxide synthase; Neoangiogenesis; Recombinant human erythropoietin; Vascular endothelial growth factor; Wound healing

Indexed keywords

BIOCHEMICAL MARKER; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN; HEMOPOIETIC GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN; WATER;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; ERYTHROCYTE COUNT; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; IMMERSION; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

EID: 33645825434     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000005780     Document Type: Erratum

References (39)

1. Jelkmann W: Biology of erythropoietin. Clin Invest 1994; 72:S310
2. Alvarez Arroyo MV, Castilla MA, Gonzalez Pacheco FR, et al: Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol 1998; 9:1998-2004
3. Ammarguellat F, Gogusev J, Drueke TB: Direct effect of erythropoietin on rat vascular smooth muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 1996; 11:687-692
4. Haller H, Christel C, Dannenberg L, et al: Signal transduction of erythropoietin in endothelial cells. Kidney Int 1996; 50:481-488
5. Metcalf D: Peptide factors, haemopoietic growth factors. Lancet 1989; 1:825-827
6. Risau W: Mechanisms of angiogenesis. Nature 1997; 386:671-674
7. Ribatti D, Presta M, Vacca A, et al: Human erythropoietin induces a proangiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93:2627-2636
8. Anagnostou A, Lee ES, Kesseimian N, et al: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 1990; 87:5978-5982
9. Buemi M, Vaccaro M, Sturiale A, et al: Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol 2002; 82:411-417
10. Haroon Za, Amin K, Jiang X, et al: A novel role for erythropoietin during fibrin-induced wound healing response. Am J Pathol 2003; 163:993-1000
11. Artuson G: Pathophysiology of burn wound and pharmacological treatment. Burns 1995; 22:255-274
12. Lawrence WT, Diegelmann RF: Growth factors in wound healing. Clin Dermatol 1994; 12:157-169
13. Becker WK, Shippee RL, Mcmanus AT, et al: Kinetics of nitrogen oxide production following experimental thermal injury in rats. J Trauma 1993; 34:855-862
14. Gamelli RL, George M, Sharp-Pucci M, et al: Burn-induced nitric oxide release in humans. J Trauma 1995; 39:869-878
15. Akcay MN, Ozcan O, Gundogdu C, et al: Effect on nitric oxide synthase inhibitor on experimentally induced burn wounds. J Trauma 2000; 49:327-330
16. Paulsen SM, Wurster SH, Nanney LB: Expression of inducible nitric oxide synthase in human burn wounds. Wound Repair Reg 1998; 6:142-148
17. Galeano M, Altavilla D, Cucinotta D, et al: Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004; 53:2509-2517
18. Tsuboi R, Rifkin DB: Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 1990; 172:245-251
19. Altavilla D, Galeano M, Bitto A, et al: Lipid peroxidation inhibition by raxofelast improves angiogenesis and wound healing in experimental burn wounds. Shock 2005; 24:85-91
20. Galeano M, Deodato B, Altavilla D, et al: Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 2003; 31:1017-1025
21. Yamamoto T, Horikawa N, Komuro Y, et al: Effect of topical application of a stable prostacyclin analogue, SM-10902 on wound healing in diabetic mice. Eur J Pharmacol 1996; 302:53-60
22. Hsu SM, Raine L, Fanger H: Use of avidinbiotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody(PAP) procedures. J Histochem Cytochem 1981; 29:577-580
23. Friedl HP, Till GO, Trentz O, et al: Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am J Pathol 1989; 135:203-217
24. Sabeh F, Hockberger P, Sayeed MM: Signaling mechanisms of elevated neutrophil O2generation after burn injury. Am J Physiol 1998; 274:R476-R485
25. Lund T, Onarheim H, Reed RK: Pathogenesis of edema formation in burn injuries. World J Surg 1992; 16:29
26. Zawacki BE: The natural history of reversible burn injury. Surg Gynecol Obstet 1974; 139:867-872
27. Altavilla D, Saitta A, Cucinotta D, et al: Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis. Diabetes 2001; 50:667-674
28. Ping Shi H, Efron DT, Most D, et al: The role of iNOS in wound healing. Surgery 2001; 130:225-229
29. Fukumura D, Jain RK: Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancers Metastasis Rev 17:77-89
30. Ignarro LJ Cirino G, Casini C, et al: Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 1999; 34:879-886
31. Lindblom L, Cassuto J, Yregard L, et al: Importance of nitric oxide in the regulation of burn oedema, proteinuria and urine ouput. Burns 200; 26:13-17
32. Figueroa XF, Martinez AD, Gonzalez DR, et al: In vivo assessment of microvascular nitric oxide production and its regulation with blow flow. Am J Physiol Heart Circ Physiol 2001; 280:H1222-H1231
33. Azuma H, Ishikawa M, Sekizaki S: Endothelium dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88:411-415
34. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2:1057-1058
35. Ianaro A, Ialenti A, Sautebin L, et al: Nitric oxide inhibits neutrophil infiltration in the reverse passive arthus reaction in rat skin. Naunyn Schmiedebergs Arch Pharmacol 1998; 358:489-495
36. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88:4651-4655
37. Ehrlich HP, Needle AL, Rajaratnam J, et al: The role of prostacyclin and thromboxane in rat burn and freeze injuries. Expo Mol Pathol 1983; 38:357-367
38. Kupper TS, Deitch EA, Baker CC, et al: The human burn wound as a primary source of interleukin1 activity. Surgery 1986; 100:409-415
39. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994; 269:4355-4359